Advertisement

Heterogeneity of Binding Sites for Triphenylethylene Antiestrogens in Estrogen Target Tissues

  • Alberto Gulino
  • Jorge Raul Pasqualini

Abstract

Most of the interest in understanding the mechanism of action of triphenylethylene antiestrogens (Fig. 1) arises from their ability to induce weak estrogenic effects, to antagonize many of the actions of estrogens and to induce the remission of human breast cancer particularly during the post-menopausal period (Legha et al., 1978). In particular, these compounds are able to suppress estrogen-induced uterine growth (Jordan et al., 1977) and to antagonize estrogen-induced growth of human breast cancer cells which contain estrogen receptor (Lippman et al., 1976). In this regard, triphenylethylene antiestrogens are used for understanding the mechanism by which estrogens regulate cell growth. However, triphenylethylene antiestrogens are also able to inhibit the growth of estrogen sensitive and estrogen receptor containing human breast cancer cells, even in the absence of estrogens (Lippman et al., 1976). The attempt to understand the mechanism of action of both estrogen and antiestrogens awaits the elucidation of the molecular events and interactions which occur at the subcellular and cellular level. In recent years, multiple interactions of triphenylethylene antiestrogens have been reported at the subcellular level: a) the interaction with the estrogen receptor system (Terenius, 1971; Lippman et al., 1976; Horwitz and McGuire, 1978), and b) the binding of these compounds to specific binding sites distinct from the estrogen receptor in several experimental models such as the chick oviduct (Sutherland and Foo, 1979), rat uterus (Faye et al., 1980), fetal guinea pig uterus (Gulino and Pasqualini, 1980), human mammary cancer (Sutherland and Murphy, 1980) and human myometrium (Kon, 1983). The aim of this paper is to summarize the data so far known about the interactions of triphenylethylene antiestrogens with target cells at the subcellular level.

Keywords

Human Breast Cancer Cell Ratio Competitor Fetal Organ Estrogen Receptor Level Antiestrogen Binding Site 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baudendistel, L. J., and Ruh, T. S., 1976, Antiestrogen action: differential nuclear retention and extractibility of the estrogen receptor, Steroids, 28: 223.PubMedCrossRefGoogle Scholar
  2. Clark, J. H., and Peck, Jr., E. J., 1979, “Female Sex Steroids, Receptors and Function,” Springer-Verlag, Berlin - Heidelberg.CrossRefGoogle Scholar
  3. Coezy, E., Borgna, J. L., and Rochefort, H., 1982, Tamoxifen and metabolites in MCF-7 cells: correlation between binding to estrogen receptors and inhibition of cell growth, Cancer Res., 42: 317.Google Scholar
  4. Eckert, R. L., and Katzenellenbogen, B. S., 1982, Physical proper- ties of estrogen receptor complexes in MCF-7 human breast cancer cells-Differences with antiestrogen and estrogen, J. Biol. Chem., 257: 8840.PubMedGoogle Scholar
  5. Evans, E., Baskevitch, P. P., and Rochefort, H., 1982, Estrogen receptor. DNA interaction: differences between activation by estrogen and antiestrogen, Europ. J. Biochem., 128: 185.PubMedCrossRefGoogle Scholar
  6. Faye, J. C., Lasserre, B., and Bayard, F., 1980, Antiestrogen specific, high affinity, saturable binding sites in rat uterine cytosol, Biochem. Biophys. Res. Commun., 93: 1225.PubMedCrossRefGoogle Scholar
  7. Green, M. D., Whybourne, A. M., Taylor, I. W., and Sutherland, R. L., 1981, Effects of antioestrogens on the growth and cell kinetics of cultured human mammary carcinoma cells, in: “Non-Steroidal Antioestrogens,” R. L. Sutherland, and V. C. Jordan, eds, Academic Press, Sidney.Google Scholar
  8. Gulino, A., and Pasqualini, J. R., 1980, Specific binding and biological response of antiestrogens in the fetal uterus of the guinea pig, Cancer Res., 40: 3821.PubMedGoogle Scholar
  9. Gulino, A., and Pasqualini, J. R., 1982, Heterogeneity of binding sites for tamoxifen and tamoxifen derivatives in estrogen target and non target fetal organs of guinea pig, Cancer Res., 42: 1913.PubMedGoogle Scholar
  10. Gulino, A., and Pasqualini, J. R., 1983, Modulation of tamoxifenspecific binding sites and estrogen receptors by estradiol and progesterone in the neonatal uterus of guinea pig, Endocrinology, 112: 1871.PubMedCrossRefGoogle Scholar
  11. Horwitz, K. B., and McGuire, W. L., 1978, Nuclear mechanism of estrogen action. J. Biol. Chem., 253: 8185.PubMedGoogle Scholar
  12. Horwitz, K. B., Yoshiro, K., and McGuire, W. L., 1978, Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen, Endocrinology, 103: 1742.PubMedCrossRefGoogle Scholar
  13. Jordan, V. C., Dix, C. J., Rowsby, L., and Prestwich, G., 1977, Studies on the mechanism of action of the non steroidal anti-oestrogen tamoxifen (ICI 46.474) in the rat, Mol. Cell. Endocrinol., 7: 177.PubMedCrossRefGoogle Scholar
  14. Kon, O. L., 1983, An antiestrogen-binding protein in human tissues, J. Biol. Chem., 258: 3173.PubMedGoogle Scholar
  15. Legha, S. S., Davis, A. L., and Muggia, F. M., 1978, Hormonal therapy of breast cancer: new approaches and concepts, Ann. Intern. Med., 88: 69.PubMedGoogle Scholar
  16. Lippman, M. E., Bolan, G., and Huff, K., 1976, The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture, Cancer Res., 36: 4595.PubMedGoogle Scholar
  17. Miller, M. A., and Katzenellenbogen, B. S., 1983, Characterization and quantitation of antiestrogen binding sites in estrogen receptor-positive and negative human breast cancer cell lines, Cancer Res., 43: 3094.PubMedGoogle Scholar
  18. Murphy, L. C., and Sutherland, R. L., 1983, Antitumor activity of Clomiphene analogs in vitro: relationship to affinity for the estrogen receptor and another high affinity antiestrogen binding site, J. Clin. Endocr. Metab., 57: 373.PubMedCrossRefGoogle Scholar
  19. Pasqualini, J. R., and Nguyen, B. L., 1976, Mise en évidence des récepteurs cytosoliques et nucléaires de l’oestradiol dans l’utérus de foetus de cobaye, C.R. Acad. Sci., ( Série D) (Paris ) 283: 413.Google Scholar
  20. Pasqualini, J. R., and Nguyen, B. L., 1980, Progesterone receptors in the fetal uterus and ovary of the guinea pig: evolution during fetal development and induction and stimulation in estradiol-primed animals, Endocrinology, 106: 1160.PubMedCrossRefGoogle Scholar
  21. Pasqualini, J. R., Cosquer-Clavreul, C., and Gelly, C., 1983, Rapid modulation by progesterone and tamoxifen of estradiol effects on nuclear histone acetylation in the uterus of the fetal guinea pig, Biochim. Biophys. Acta, 739: 137.PubMedGoogle Scholar
  22. Pasqualini, J. R., Sumida, C., Gulino, A., Nguyen, B. L., Tardy, J., and Gelly, C., 1980, Recent data on receptors and biological action of estrogens and antiestrogens in the fetal uterus of guinea pig, in: “Hormones and Cancer,” S. Iacobelli, R. J. B. King, H. R. Lindner, and M. E. Lippman, eds, Raven Press, New York.Google Scholar
  23. Patterson, J., Furr, B., Wakeling, A., and Battersby, L., 1982, The biological physiology of Nolvadex ( Tamoxifen) in the treatment of breast cancer, Breast Cancer Res. and Treat., 2: 363.CrossRefGoogle Scholar
  24. Rochefort, H., and Borgna, J. L., 1981, Differences between the activation of the estrogen receptor by estrogen and anti-estrogen, Nature, 292: 257.PubMedCrossRefGoogle Scholar
  25. Scatchard, G., 1949, The attractions of proteins for small molecules and ions, Ann. N. Y. Acad. Sci., 51: 660.CrossRefGoogle Scholar
  26. Screpanti, I., Gulino, A., and Pasqualini, J. R., 1982, The fetal thymus of guinea pig as an estrogen target organ, Endocrinology, 111: 1552.PubMedCrossRefGoogle Scholar
  27. Sudo, K., Monsma, Jr., F. J., and Katzenellenbogen, B. S., 1983, Antiestrogen binding sites distinct from the estrogen receptor: subcellular localization, ligand specificity and distribution in tissues of the rat, Endocrinology, 112: 425.PubMedCrossRefGoogle Scholar
  28. Sumida, C., and Pasqualini, J. R., 1980, Dynamic studies on estrogen responses in fetal guinea pig uterus: effect of estradiol administration on estradiol receptor, progesterone receptor and uterine growth, J. Receptor Res., 1: 439.Google Scholar
  29. Sutherland, R. L., and Foo, M. S., 1979, Differential binding of antiestrogens by rat uterine and chick oviduct cytosol. Biochem. Biophys. Res. Commun., 91: 183.PubMedCrossRefGoogle Scholar
  30. Sutherland, R. L., and Murphy, L. C., 1980, The binding of tamoxifen to human mammary carcinoma cytosol, Europ. J. Cancer, 16: 1141.CrossRefGoogle Scholar
  31. Sutherland, R. L., Green, M. D., Hall, R. E., Reddel, R. R., and Taylor, I. W., 1983, Tamoxifen induces accumulation of MCF-7 human mammary carcinoma cells in the GO/G1 phase of the cycle, Europ. J. Cancer Clin. Oncol., 19: 615.PubMedCrossRefGoogle Scholar
  32. Sutherland, R. L., Murphy, L. C., Foo, M. S., Green, M. D., Whybourne, A. M., and Krozowski, Z. S., 1980, High affinity antioestrogen binding site distinct from the oestrogen receptor, Nature, 288; 273.PubMedCrossRefGoogle Scholar
  33. Terenius, L., 1971, Structure-activity relationships of antiestrogens with regard to interaction with 1713-estradiol in the mouse uterus and vagina, Acta Endocrinol. ( Copenh. ), 66: 431.Google Scholar
  34. Terpstra, A. H. M., Woodward, C. J. H., and Sanchez-Muniz F. J., 1981, Improved techniques for the separation of serum lipoproteins by density gradient ultracentrifugation: visualization by prestaining and rapid separation of serum lipoproteins from small volumes of serum, Anal. Biochem., 111: 149.PubMedCrossRefGoogle Scholar
  35. Westley, B., and Rochefort, H., 1980, A secreted glycoprotein induced by estrogen in human breast cancer cell lines, Cell, 20: 353.PubMedCrossRefGoogle Scholar
  36. Winneker, R. C., and Clark, J. H., 1983, Estrogenic stimulation of the antiestrogen specific binding site in rat uterus and liver, Endocrinology, 112: 1910.PubMedCrossRefGoogle Scholar
  37. Winneker, R. C., Sylvia, C. G., and Clark, J. H., 1983, Characterization of a triphenylethylene antiestrogen binding site on rat serum low density lipoproteins, Endocrinology, 112: 1823.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Alberto Gulino
    • 1
  • Jorge Raul Pasqualini
    • 1
  1. 1.C.N.R.S. Steroid Hormone Research UnitFoundation for Hormone ResearchParisFrance

Personalised recommendations